Wall Street Analysts Think Castle Biosciences (CSTL) Could Surge 51.52%: Read This Before Placing a Bet
Portfolio Pulse from
Analysts predict a potential 51.5% upside for Castle Biosciences (CSTL) based on price targets and raised earnings estimates.
January 29, 2025 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Castle Biosciences (CSTL) is projected to have a 51.5% upside based on analysts' price targets and raised earnings estimates.
The article highlights a significant potential upside for CSTL based on analysts' price targets and consensus on raised earnings estimates. This suggests a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100